The art and science of running a successful pharmaceutical company.
May 14, 2013
By:
Pete Mehr, PhD, Merkle
This paper focuses on how customer centricity can unlock significant financial gains for pharmaceutical companies. It briefly reviews the historical promotion model, the factors in the industry that are driving the change, and then goes into depth on what it means to be customer centric and how to implement a customer-centric model.
|
March 1, 2013
By:
Ben Bonifant, Scott Setrakian
Companies that adopt this new methodology will have a longstanding competitive advantage over those companies conducting business as usual.
|
March 1, 2013
By:
Alyse Forcellina, Can Akannac
A proactive approach to talent and organization planning is the hidden trump card in prevailing with payers.
|
March 1, 2013
By:
Ken Getz
Ken Getz of the Tufts University Center for the Study of Drug Development (CSDD) explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.
|
|
February 1, 2013
By:
Stan Bernard, MD
"Drug Life Optimization" can wrest more value through strategies that build a drug's brand franchise through its entire lifespan, according to Stan Bernard.
|
|
January 1, 2013
By:
Kenneth Getz, Mary Jo Lamberti
New research sheds fresh light on a trend with serious consequences for the public health—not only in the United States but for patients worldwide.
|
|
November 1, 2012
Chinese start-ups have realized that they need to recruit highly skilled and globally oriented general managers from foreign multinationals when they reach a critical size.
|
November 1, 2012
Unified payer research planning is of top import.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
